Endocyte Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
64,870.90
70,353.50
70.00
70.00
70.00
SG&A Expense
82,538.00
59,069.70
41,022.20
43,870.50
36,414.00
EBIT
18,341.80
10,426.70
41,838.90
44,720.30
37,266.70
Unusual Expense
-
5,400.00
134.00
-
18,839.30
Non Operating Income/Expense
153.70
144.70
51.60
28.50
12.40
Interest Expense
2.50
1.20
-
-
-
Pretax Income
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
Consolidated Net Income
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
Net Income
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
Net Income After Extraordinaries
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
Net Income Available to Common
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
EPS (Basic)
0.50
0.13
0.98
1.04
1.25
Basic Shares Outstanding
36,037.00
40,242.40
41,939.50
42,210.60
43,900.30
EPS (Diluted)
0.50
0.13
0.98
1.04
1.25
Diluted Shares Outstanding
36,037.00
41,758.10
41,939.50
42,210.60
43,900.30
EBITDA
17,667.10
11,283.80
40,952.20
43,800.50
36,344.00
Non-Operating Interest Income
465.50
578.60
651.50
861.20
1,029.50
About Endocyte
View Profile
